152368-17-7 Usage
Classification
Pyranone derivative
Structural features
Morpholinylmethyl group attached to the pyranone ring, hydroxy group at the 5 position
Uses
Potential drug candidate for therapeutic applications such as anti-inflammatory and anti-cancer agent
Additional properties
Studied for antioxidant and neuroprotective properties
Ongoing research
Exploring potential medicinal uses and pharmacological properties
Check Digit Verification of cas no
The CAS Registry Mumber 152368-17-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,2,3,6 and 8 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 152368-17:
(8*1)+(7*5)+(6*2)+(5*3)+(4*6)+(3*8)+(2*1)+(1*7)=127
127 % 10 = 7
So 152368-17-7 is a valid CAS Registry Number.
152368-17-7Relevant articles and documents
Methods of treating nervous disorders
-
Page/Page column 10, (2008/06/13)
The invention relates to compositions and methods for treating nervous disorders. More particularly, the invention relates to methods of treating amylo?d beta peptide-related disorders, particularly Alzheimer's disease, using Rac1 inhibitors. The invention may be used in mammalian subjects, particularly human subjects, at various stages of the disease, including disease onset. The invention also provides methods of producing, identifying, selecting or optimising compounds for use in the treatment of amylo?d beta peptide-related disorders, based on a determination of the ability of a test compound to inhibit Rac1.
